Progenics Pharmaceuticals Inc (PGNX.OQ)
27 Nov 2015
* Said on Monday at the request of Progenics Pharmaceuticals, Inc, the board of Exini has resolved to apply for voluntary removal of the shares from trading on First North
* Progenics Pharmaceuticals Inc has on Oct 13 announced offer to tender all of shares in Exini for a consideration of 3.15 Swedish crowns per share
A federal jury ordered biotechnology company Progenics Pharmaceuticals Inc to pay $1.66 million, after finding that it retaliated against a former chemist in violation of whistleblower protections enacted after the Enron Corp scandal.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥6,174||-30.00|
|AstraZeneca plc (AZN.L)||4,512.50p||-7.50|
|Cubist Pharmaceuticals Inc (CBST.OQ)||--||--|
|Nektar Therapeutics (NKTR.OQ)||$15.21||-0.43|
|Medivation Inc (MDVN.OQ)||$41.68||+0.51|
|Sucampo Pharmaceuticals, Inc. (SCMP.OQ)||$18.22||+0.13|
|Theravance Inc (THRX.OQ)||$9.08||+0.05|
|Shionogi & Co Ltd (4507.T)||¥5,550||-46.00|
|Johnson & Johnson (JNJ.N)||$102.37||+0.41|
|Jazz Pharmaceuticals PLC (JAZZ.OQ)||$149.42||-1.03|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (PGNX). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : S&P Capital IQ Quantitative Report
Progenics Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : Ford Investor Services, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.